Daniel Goff speaks at the 2011 CIRM Grantee Meeting about identifying potential leukemia drugs that could zero-in on and kill the cancer stems cells that are thought to be responsible for relapse after chemotherapy treatment. Goff is a CIRM Scholar and PhD student at UC San Diego.